A look at Checkpoint Therapeutics Inc’s (CKPT) recent performance gives investors their first glimpse of hope.

Checkpoint Therapeutics Inc (NASDAQ: CKPT) kicked off on Tuesday, remained unchanged from the previous trading day, before settling in for the closing price of $4.04. Over the past 52 weeks, CKPT has traded in a range of $1.38-$4.50.

Healthcare Sector giant saw their annual sales slid by -49.45% over the last five years. While this was happening, its average annual earnings per share was recorded 82.04%. With a float of $64.48 million, this company’s outstanding shares have now reached $87.02 million.

The firm has a total of 24 workers. Let’s measure their productivity. In terms of profitability, gross margin is -31551.22%, operating margin of -137009.76%, and the pretax margin is -137170.73%.

Checkpoint Therapeutics Inc (CKPT) Insider Activity

Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Checkpoint Therapeutics Inc is 25.90%, while institutional ownership is 23.19%. The most recent insider transaction that took place on Apr 02 ’25, was worth 60,964. In this transaction CEO, President and Director of this company sold 15,090 shares at a rate of $4.04, taking the stock ownership to the 3,759,929 shares. Before that another transaction happened on Apr 01 ’25, when Company’s Chief Financial Officer sold 12,322 for $4.05, making the entire transaction worth $49,904. This insider now owns 1,446,322 shares in total.

Checkpoint Therapeutics Inc (CKPT) Earnings and Forecasts

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.02 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 82.04% per share during the next fiscal year.

Checkpoint Therapeutics Inc (NASDAQ: CKPT) Trading Performance Indicators

Take a look at Checkpoint Therapeutics Inc’s (CKPT) current performance indicators. Last quarter, stock had a quick ratio of 0.37. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8789.00.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.27, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach 1.13 in one year’s time.

Technical Analysis of Checkpoint Therapeutics Inc (CKPT)

Analysing the last 5-days average volume posted by the [Checkpoint Therapeutics Inc, CKPT], we can find that recorded value of 0.94 million was lower than the volume posted last year of 2.34 million. As of the previous 9 days, the stock’s Stochastic %D was 100.00%. Additionally, its Average True Range was 0.07.

During the past 100 days, Checkpoint Therapeutics Inc’s (CKPT) raw stochastic average was set at 78.45%, which indicates a significant decrease from 90.91% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 8.38% in the past 14 days, which was lower than the 100.68% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $3.61, while its 200-day Moving Average is $3.09. Now, the first resistance to watch is $4.04. This is followed by the second major resistance level at $4.05. The third major resistance level sits at $4.05. If the price goes on to break the first support level at $4.03, it is likely to go to the next support level at $4.03. Should the price break the second support level, the third support level stands at $4.02.

Checkpoint Therapeutics Inc (NASDAQ: CKPT) Key Stats

The company with the Market Capitalisation of 351.56 million has total of 83,764K Shares Outstanding. Its annual sales at the moment are 40 K in contrast with the sum of -56,240 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -9,730 K.